false statements

Rosen Law Firm solicits $SMCI investors for class action alleging false statements about Chinese sales violating export controls. Lead plaintiff deadline: May 26, 2026.

Rosen Law Firm urges $APO investors to join securities class action alleging executives falsely denied Jeffrey Epstein business relationships between May 2021 and February 2026.

Stellantis faces securities class action over alleged false earnings and EV strategy statements. Investors who purchased $STLA between Feb 2025-Feb 2026 may qualify; June 8 deadline looms.

Rosen Law Firm urges $PSIX investors to join securities class action lawsuit before May 19, 2026 deadline. Eligible shareholders may recover losses from alleged securities violations.

Rosen Law Firm urges Coty investors to join class action by May 22, 2026 deadline, citing false statements on beauty market growth and segment performance.

Rosen Law Firm initiates class action against $ENPH for alleged misstatements on inventory management and tax credit impacts. April 20, 2026 lead plaintiff deadline.

Atara Biotherapeutics faces class action lawsuit alleging false statements about manufacturing and ALLELE study deficiencies. Lead plaintiff deadline set for May 22, 2026.

Rosen Law Firm files securities class action against Lufax Holding Ltd ($LU), alleging false statements. Investors must act before approaching lead plaintiff deadline.

Boston Scientific faces securities class action over alleged Electrophysiology segment disclosure failures. Investors must act by May 4, 2026 deadline.

Securities lawsuit filed against $ALIT alleges false statements on growth potential and financial stability. Investors who bought stock between November 2024 and February 2026 may qualify for compensation.

Class action lawsuit filed against Pinterest alleges false statements on ad revenue, tariff impacts, and undisclosed restructuring. Lead plaintiff deadline set for May 29, 2026.

Class action lawsuit filed against $NKTR alleging false statements about REZOLVE-AA trial enrollment and integrity. Lead plaintiff deadline set for May 5, 2026.

Class action lawsuit filed against $APO alleging leadership made false statements about Jeffrey Epstein relationship, harming investors between May 2021 and February 2026.

Schall Law Firm launches class action against Coty Inc. for allegedly concealing slowing growth and margin pressures while touting fiscal 2026 prospects.

Schall Law Firm files class action against Gemini Space Station over alleged false statements on crypto platform viability and financial outlook since IPO.

Schall Law Firm seeks lead plaintiff for class action against $IT over alleged false statements regarding seasonality risks and tariff-impacted business growth.

Medpace faces class action suit alleging false guidance on cancellation rates. Stock plunged 15.9% after Q4 2025 miss, triggering investor claims.

Stellantis shareholders can file claims by June 8, 2026, in lawsuit alleging false earnings statements and concealed EV adoption risks that triggered stock collapse.

Class action lawsuit filed against $IT over alleged misleading growth projections. Stock fell 27.55% and 20.87% after earnings misses. Lead plaintiff deadline May 18, 2026.

Corcept Therapeutics ($CORT) faces securities lawsuit over alleged false FDA statements on relacorilant. Lead plaintiff deadline: April 21, 2026.